![20th Anniversary - Logos [RGB]_Growth](/media/131950/20th-anniversary-logos-rgb-_growth.png)
- Sign up for latest news
- Send us an email
- Call +44 (0)20 8069 5000
- London
- Lyon
- Singapore
- Boston
- New York
- Philadelphia
- San Francisco
Our people
Our 170 market research consultants, located across our 7 global offices, are committed to providing a high quality service, intelligent thinking, market research expertise and therapy knowledge on every project
We recognise that our people are our business
Between them, our senior team have more than 400 years of market research experience. We have specialists in quantitative and qualitative research, emerging markets experts, innovators of digital research techniques, patient advocates and market understanding gurus. Our researchers come from a range of educational backgrounds in the sciences, arts and humanities and speak over 20 languages, including Greek, Swedish, French, Czech and Dutch.
We love research and have a passion for healthcare
But we also like travelling the world, baking cakes, strumming guitar, writing books, playing hockey, DJ’ing and sailing boats. That’s just us.
Find out what more about our people and what it’s like to work here in our short film. »
- Some example case studiesHow Paediatricians and GPs revealed key insights to help develop a science story for a child nutritional supplement
The challenge:Our client needed to develop a science story in order to increase uptake for their child nutritional supplement. Research was required in order to define the patient target, frame the challenge of growth delays to be an effective call to action, articulate objectives for the product and the best way to express its value proposition. The solution:We conducted a mix of “workshop-style” focus groups…
read more »How we helped our client to understand the opportunities across Asia and other emerging markets using interactive outputsThe challenge:Our client needed to understand why the use of statins in type 2 diabetes patients in South Korea, China, Thailand and other developing countries is low / sub-optimal. Research was required to understand the diabetic patient journey in order to assess the opportunities to expand HCP knowledge on the importance of lipid lowering for type 2 diabetes patients. The client also wanted to explore…
read more »How we used a hybrid qual-quant methodology to assess the market opportunity for a new rare disease treatmentThe challenge: Our client is a recently established independent biopharmaceutical company specialising in small molecule development. They were developing a new oral compound for the treatment of a rare genetic disease for which the standard treatment is administered intravenously, however a large proportion of patients receive monitoring only or remain undiagnosed. Their objective was to successfully launch their product in order to provide clinically meaningful…
read more » - Our latest awardsResearch Partnership and Janssen awarded runner-up in the EphMRA MR Excellence Awards
We are delighted to announce that an entry submitted by Janssen and Research Partnership for the 2019 EphMRA MR Excellence Awards has been awarded runner-up in the ‘Business Impact through Innovation’ category.
read more »Janssen & Research Partnership win prestigious BHBIA Best Business Impact awardWe are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in London for our collaborative market research and consultancy work. The ‘Best Business Impact’ category, sponsored by Branding Science, is awarded for insights which have significantly increased a client's understanding of one or more of their…
read more »Research Partnership and Janssen are 2017-18 BOBI Awards finalistsWe are delighted to announce that an entry submitted by Research Partnership with Janssen has been selected as a finalist in the Best Business Impact category at this year’s BOBI (Best of Business Intelligence) Awards for our combined work in helping to reverse the fortunes of one of their established products, which up until recently had been suffering from declining market growth in the UK.…
read more »